Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pycnogenol for Arm Lymphedema in Breast Cancer Survivors
NCT00214032Phase 2Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- May 2002
- Primary completion
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in lymphedema comparing Pycnogenol with Placebo (2 arms). Primary endpoint: Reduction of arm lymphedema. Started May 2002; status: completed.
02
Drugs
grape seed extract
03
Conditions
lymphedema
Beyond the preview
Go deeper on NCT00214032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00214032.